Parexel International (ma) Corporation
Location
Massachusetts
Founded
1983-02-28
Website
Risk Signals
451 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Parexel International (ma) Corporation
Live alerts from global media, monitored by Business Radar
2025-03-09 (pharmatutor.org)
PAREXEL Hiring Document Specialist |
Compile appendices to clinical study reports in compliance with appropriate regulatory requirements, with support of the project lead and lead medical writer. Work with internal or external Clinical and or Project Leadership functions to ensure that appendix documentation is complete and complies with the relevant guidelines.
Read more
2024-10-22 (medicaldialogues.in)
Parexel International Clinical Research gets CDSCO Panel nod to study Dexpramipexole dihydrochloride monohydrate
New Delhi: Parexel has a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) to conduct the phase III clinical study of...
Read more
2024-10-05 (pharmatutor.org)
Join PAREXEL as Regulatory Affairs Associate
PAREXEL has supported the Bio-Tech and Pharmaceutical industries in helping the development of new drugs and treatments on a global basis. As a leading global biopharmaceutical service provider, they supply knowledge-based contract research, medical communications and consulting services across a
Read more
2024-09-24 (news8.de)
Global Clinical Trial Imaging Market Size, Growth, Report 2031
Global clinical trial imaging market is projected to witness a CAGR of 8.01% during the forecast period 2024-2031,...
Read more
2024-09-19 (pharmaboardroom.com)
Top 10 CROs in 2024
Contract research organisations (CROs) have proven to be increasingly vital partners for the global biopharmaceutical industry guaranteeing efficient and compliant clinical trials that help to advance their candidates towards regulatory approvals. CROs have also demonstrated their ability to adapt
Read more
2024-09-17 (newscast.jp)
Global medical contract research organization market expected to reach USD 80.45 billion by 2032: Key players and technological advances accelerating drug discovery
The global contract research organization (CRO) market remains steady at US$43.76 billion. According to recent market analysis, it is expected to grow to $80.45 billion in 10 years, at a compound annual growth rate (CAGR) of 7%.
Read more
2024-09-13 (newstrail.com)
Regulatory Information Management Market Touching New Development Level: Acuta, Ennov, Parexel
HTF Market Intelligence published a new research document of 150+pages on Regulatory Information Management Market Insights, to 2030" with self-explained
Read more
2024-09-09 (openpr.com)
Contract Research Organization Market is estimated to reach US$ 170,427.41 million by 2031- IQVIA, Parexel & Syneos Health.
Press release - DataM Intelligence 4market Research LLP - Contract Research Organization Market is estimated to reach US$ 170,427.41 million by 2031- IQVIA, Parexel & Syneos Health. - published on openPR.com
Read more
2024-08-23 (clinicalleader.com)
Biotech Innovation: Linking Real-World Data And Patient Insights To Help Demonstrate Asset Value
Real-world data (RWD) in clinical research often lacks detail on patients' personal characteristics and treatment experiences. In this example, our...
Read more